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ABSTRACT
The Gene Ontology resource (GO; http:
//geneontology.org) provides structured, com-
putable knowledge regarding the functions of genes
and gene products. Founded in 1998, GO has
become widely adopted in the life sciences, and its
contents are under continual improvement, both in
quantity and in quality. Here, we report the major
developments of the GO resource during the past
two years. Each monthly release of the GO resource
is now packaged and given a unique identifier (DOI),
enabling GO-based analyses on a specific release to
be reproduced in the future. The molecular function
ontology has been refactored to better represent the
overall activities of gene products, with a focus on
transcription regulator activities. Quality assurance
efforts have been ramped up to address potentially
out-of-date or inaccurate annotations. New evidence
codes for high-throughput experiments now enable
users to filter out annotations obtained from these
sources. GO-CAM, a new framework for representing
gene function that is more expressive than standard
GO annotations, has been released, and users
can now explore the growing repository of these
models. We also provide the ‘GO ribbon’ widget for
visualizing GO annotations to a gene; the widget
can be easily embedded in any web page.
INTRODUCTION
TheGeneOntology resource (GO; http://geneontology.org)
is the most comprehensive and widely used knowledge-
base concerning the functions of genes. In GO, all func-
tional knowledge is structured and represented in a form
amenable to computational analysis, which is essential to
support modern biological research. The GO knowledge-
base is structured using a formal ontology, by defining
classes of gene functions (GO terms) that have specified re-
lations to each other (Figure 1A). GO terms are often given
logical definitions, or equivalence axioms, that define the
term relative to other terms in the GO or other ontolo-
gies, so that their relationships can be computationally in-
ferred using logical reasoning (Figure 1B). The GO struc-
ture has been meticulously constructed over the course of
20 years by a small team of ontology developers; it is con-
stantly evolving in response to new scientific discoveries and
continuously refined to represent the most current state of
biological knowledge. The members of the ontology devel-
opment team are expert biologists and knowledge represen-
tation specialists who read the scientific literature and en-
gage biocurators and biological domain experts to collab-
oratively develop this representation of biological informa-
tion.
We present here the most important updates since our
last contribution to this series (1). There are currently over
45 000 terms in the ontology, linked by almost 134 000 re-
lations. The ontology covers three distinct aspects of gene
function: molecular function (the activity of a gene product
at the molecular level), cellular component (the location of
a gene product’s activity relative to biological structures),
and biological process (a larger biological program in which
a gene’s molecular function is utilized).
The GO knowledgebase also includes GO annotations,
created by linking specific gene products (from organ-
isms across the tree of life) to the terms in the ontology.
Each annotation includes the evidence it is based upon,
such as a peer-reviewed publication, using evidence codes
from the Evidence and Conclusion Ontology (ECO) (2).
For example, in its simplest form (what we refer to as a
standard annotation), an annotation might state that ‘hu-
man MSH2 (a gene, HGNC:7325, also represented by
UniProtKB:P43246) is involved in ‘GO:0006298 DNAmis-
match repair’ (a GO term), based on a ‘ECO:0000314 di-
rect assay evidence used in manual assertion’ reported in
(4)’. Formally, this annotation would be represented in
the knowledgebase as a ‘triple’ linking the gene to the
GO term using a specific relation: UniProtKB:P43246 in-
volved in GO:0006298. The GO knowledgebase contains
over 7 million annotations to genes/gene products from
over 3,200 species (http://amigo.geneontology.org/amigo/
search/annotation),∼10% of which (750 000) are supported
by experimental data from research papers. Nearly half of
these 750 000 experimental annotations refer to genes in a
relatively small number of ‘model’ organisms, listed in Table
1. These annotations are made by a consortium of expert
biocurators located worldwide, who read scientific papers,
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Figure 1. GO structure. (A) Graphical representation of relationships be-
tween terms: black lines represent is a and blue lines represent part of
(representation obtained from https://www.ebi.ac.uk/QuickGO/term/GO:
0060887). (B) Equivalence axiom for the term ‘GO:0060887: limb epider-
mis development’, as displayed in Prote´ge´ (12).
ensure the correct gene is identified, and select the most ac-
curate and meaningful GO terms to describe the biology
supported by the experimental findings. The accuracy of the
GO resource is continually refined by internal checks as well
as feedback from the broader GO user community to iden-
tify and fix potentially incorrect or out-of-date annotations.
The wealth of experimental knowledgemanually curated by
biocurators is further enriched by inferences from various
predictive methods, both manual and automatic, described
using classes from ECO as described in (3). In most cases,
these annotations are inferred from one or more experi-
mental annotations to a homologous gene product. These
may be individually reviewed by a biocurator [denoted by
‘ECO:0000250 sequence similarity evidence used in manual
assertion’ (ISS) or ‘ECO:0000318 biological aspect of an-
cestor evidence used in manual assertion’ (IBA) evidence
classes] or not reviewed [denoted by ‘ECO:0000501 evi-
dence used in automatic assertion’ (IEA)].
This structure of the GO knowledgebase, the ontology
plus annotations, supports queries of the sort that are typ-
ically asked in the course of biological research, such as:
‘What are all the functions for the human ABCA1 gene?’
or ‘What are all the genes involved in the DNA mismatch
repair process?’. Because each annotation is associated with
evidence (ECO and reference), computer programs can an-
swer even more specific queries, such as ‘What genes have
direct experimental evidence of involvement in the DNA
mismatch repair process?’, or ‘Which scientific papers pro-
vide experimental evidence about the function of the hu-
man ABCA1 gene?’. The ability of the GO knowledgebase
to support computational queries is a major reason for its
standing as an essential tool in biomedical research. The
most obvious example is its use in GO enrichment analysis,
also often called pathway analysis (5). For example, a re-
searcher might have identified a set of 1000 genes expressed
at a higher level in a cancer sample than in a matched
healthy tissue sample, and would like to know if there are
any functions (terms from the GO molecular function, cel-
lular component, or biological process aspects) that are un-
usually common among these 1000 overexpressed genes to
understand what may be driving the cancer. To reach this
understanding, the functions represented in the set of 1000
genes need to be compared to the functions represented in
all 20 000 human protein-coding genes. A computer can use
the GO knowledgebase’s structure to rapidly retrieve the all
the functions that are performed by each of the 20 000 hu-
man genes, and create all possible groupings by functional
class. Each grouping is tested for statistical enrichment, and
the small number of enriched functional classes enables the
researcher to identify candidate biological processes within
the complex experimental measurement of 20,000 genes.
GO resource content
The GO knowledgebase consists of the ontology and the
annotations made using the ontology. As of the 5 Septem-
ber 2018 release (doi:10.5281/zenodo.1410625), there were
∼45 000 terms in GO: 29 698 biological processes, 11 147
molecular functions and 4201 cellular components, linked
by almost 134 000 relationships. The number of annotations
(as well as the percentage change since 2016 (1)) are shown
in Table 1. It is important to understand that the changes re-
flect two distinct processes: addition of annotations based
on new evidence, and obsoleting of annotations that have
been superseded by newer studies. We expect the number of
obsoleted annotations to increase, due to our increasing an-
notation quality assurance efforts, described in more detail
below.
New framework and repository, for gene function ‘models’.
We have developed amore expressive computational frame-
work for representing gene functions, which subsumes our
currentGO annotation framework, whilemaintaining com-
patibility.We refer to the framework as GO-Causal Activity
Modeling (GO-CAM, formerly referred to as ‘LEGO’ (1))
and to GO-CAMs asmodels to distinguish them from stan-
dard annotations. A paper detailingGO-CAM is in prepara-
tion, but we summarize some properties here. In GO-CAM,
eachmodel is represented as a set of triples (subject-relation-
object, with brackets {} as a set container), e.g. {ABCA1
enables cholesterol transporter activity; cholesterol trans-
porter activity occurs in plasma membrane, and cholesterol
transporter activity part of cholesterol homeostasis}. Each
triple is supported by one or more pieces of evidence, con-
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Table 1. Number of experimental annotations in the GO knowledgebase, 5 September 2018 release (doi:10.5281/zenodo.1410625)
Protein binding, EXP
Molecular function EXP,
excluding protein binding Cellular component EXP Biological process EXP
Human 83589 (+158%) 29999 (+26%) 41341 (+13%) 47230 (+22%)
Mouse 12990 (+49%) 14380 (+11%) 28262 (+25%) 67094 (+13%)
Rat 4329 (+2%) 10879 (−9%) 15693 (+4%) 27241 (−1%)
Zebrafish 509 (+30%) 1756 (+15%) 1087 (+16%) 21635 (+20%)
Drosophila 1516 (+33%) 5694 (+15%) 10803 (+3%) 30762 (+1%)
C. elegans 2993 (+13%) 2482 (+13%) 5245 (+8%) 14511 (+24%)
D. discoideum 690 (+32%) 1081 (+15%) 2738 (+30%) 4149 (+14%)
S. cerevisiae 168 (+58%) 8886 (+8%) 17456 (+4%) 20194 (+14%)
S. pombe 2076 (+52%) 4636 (+42%) 12184 (+8%) 5651 (+11%)
A. thaliana 13074 (+113%) 8344 (+14%) 25486 (+7%) 25223 (+12%)
E. coli 3602 (+57%) 6006 (+20%) 4171 (+7%) 5756 (+5%)
Note that for the molecular function annotations, we present annotations to ‘GO:0005515 protein binding’ separately from other GO:0003674 molecular
functions, as theseGO:0005515 annotations are used differently than other annotations (the class itself is not very informative, but each annotation includes
additional information about the specific binding partner). The number of annotations for the main species annotated by the GOC are shown, and the
percentage change relative to the 2016 update is indicated in parentheses.
sisting of a class from ECO and a citable source, usually
a scientific publication. GO-CAM specifies the semantics
of GO annotations, and how standard GO annotations can
be combined into a larger model. Each GO-CAM model
is represented using the Web Ontology Language (OWL),
which is converted computationally to standard GO an-
notations (GAF format), ensuring backward compatibility.
Users can browse, view, and download the available mod-
els in different formats at: http://geneontology.org/go-cam.
The number of models is currently small, and most models
contain only one gene product (standard annotations ex-
tended with additional contextual information, such as cell
type). The GO is currently rapidly increasing the curation
of GO-CAM models, and the model repository is growing.
In particular, models are now available that each represent
an entire regulatory or metabolic pathway.
Changes to data access: new production pipeline. Start-
ing in March 2018, the releases of the GO resource have
been generated by a new data production pipeline using
a refreshed software stack. This system allows for eas-
ily extensible error checking and improved reporting of
quality assurance checks that ensure the quality and in-
tegrity of the released ontology and annotations. For users,
one of the most important aspects of this pipeline is that
the GO resource now produces monthly releases (named
by release date) that are available at the GO site and
can be referenced and obtained as stable Document Ob-
ject Identifiers (DOIs) via Zenodo. This feature is criti-
cal for ensuring that GO-based analyses can be replicated
in a consistent and referenceable manner through the in-
clusion of these DOIs and/or version of both the ontol-
ogy and annotation files used (6). Our data production
pipeline is currently hosted at the Lawrence Berkeley Na-
tional Laboratory. We provide GO annotations in multi-
ple formats: as standard GAF (Gene Association Format)
and GPAD (Gene Product Association Data) annotation
files, in Turtle (OWL serialization format) [http://current.
geneontology.org/products/ttl], and a Blazegraph [http://
current.geneontology.org/products/blazegraph] journal, re-
placing the legacy MySQL output.
Interactions with the GO user community
GO is an open project, and we encourage community con-
tributions to the knowledgebase and software.
All users: GO can be contacted using the GO Helpdesk
(http://help.geneontology.org) for any questions or feed-
back about the annotations, the ontology, software, or other
GO resources. If users notice an annotation that may not be
correct, they should first review the original publication or
data source. If the annotation still seems inaccurate, users
are encouraged to report this to theGOhelpdesk, andGOC
members will review the annotation and remove or modify
it if justified. Authors: Authors can now see if their paper
has been used for GO annotation directly in PubMed. Un-
der the ‘LinkOut - more resources’ section of the PubMed
abstract page, papers with annotations will have a link la-
beled ‘Gene Ontology annotations from this paper - Gene
Ontology’ (see, e.g. https://www.ncbi.nlm.nih.gov/pubmed/
3357510which links to aweb page on theGO site that shows
the annotations based on evidence in that paper). If no GO
LinkOut is present, that may indicate that the publication
has not been used for GO annotation. Authors can contact
the helpdesk at the GO website to suggest new annotations
or changes to existing annotations. Resources or consortia:
The GOC collaborates with established data resources and
other groups and consortia representing a particular area
of biology. Recent examples include cilium biology (7,8),
autophagy (9) and cardiac phenotypes (10). We encourage
members of other interest groups to contact us to improve
the ontology and annotations in their areas of expertise.
Tracking all contributions: Most aspects of the GO project
management are now based in GitHub (https://github.com/
geneontology). In addition to tracking ontology change re-
quests (https://github.com/geneontology/go-ontology), we
nowuseGitHub to collect feedback on annotations (https://
github.com/geneontology/go-annotation). For users famil-
iar with GitHub, we encourage them to submit any requests
directly to GitHub, where they can follow all further dis-
cussion and actions. Otherwise, issues and queries can be
submitted to our helpdesk (http://help.geneontology.org).
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Increased focus on annotation quality control
The GO resource is now 20 years old. The longevity of
the resource adds a challenge to maintain and update the
many existing annotations, as many of the findings pub-
lished during that time have become much more precise, or
were reinterpreted or superseded. We have made it a high
priority to identify and correct inaccurate and out-of-date
legacy annotations to make sure that GO continues to con-
sistently reflect current knowledge. We have taken a num-
ber of different approaches to tackle this challenge. First,
to ensure consistency and quality, GObiocuratorsmeet reg-
ularly for training, establishment of annotation guidelines,
and coordinated review of specific areas of biology.More re-
cently, we have made significant efforts to integrate annota-
tion review with ontology improvements, taking advantage
of suggested changes to the ontology to clarify term defini-
tions, intended usage, and coordinate annotation practices
with curators. In addition, quality assurance is performed
centrally, both computationally, to ensure annotations are
valid, and manually, to ensure they accurately represent the
experimental findings.
We have discovered that one of the most powerful ap-
proaches to quality control and consistency is the phylo-
genetic approach. Originally developed as a means of prop-
agating annotations from experimentally studied genes to
evolutionarily related genes in other species, the phyloge-
netic perspective provides a unified view of all experimen-
tal annotations within a evolutionarily-related protein fam-
ily, allowing curators to more easily find outlier annotations
(see e.g. (11)). In parallel, the development of GO-CAM
models has been useful in identifying inconsistent annota-
tion practices, and has provided opportunities to develop
consortium-wide annotation guidelines. Another observa-
tion that emerged is that older annotations from isolated
phenotypic observations, taken outside of other contextual
data, often do not provide evidence of direct involvement of
a gene in a biological process. If inconsistencies are noticed,
they are reported to the contributing group for verification
and correction as appropriate.
In a pilot quality assurance effort, we have requested the
review (by GO Consortium biocurators) of ∼2500 manual
annotations (<0.01% of the total corpus) that were judged
questionable by one of the strategies above. Approximately
70–80% of the annotations flagged for review were modi-
fied to a more appropriate term or removed. We will con-
tinue to work on improving the quality of the annotations
and reviewing legacy data when appropriate. As a result,
we expect that the increase in annotations and new ontol-
ogy terms may not be as rapid as in the past, at least for
the main species annotated by the consortium members, as
a greater proportion of our efforts will be dedicated to re-
viewing and revising older annotations.
Ontology revision and integration
Since our last update article, we have developed an entirely
new process for ontology editing and maintenance that has
dramatically increased efficiency and enabled extensive real-
time quality checks. Ontology editing is now performed in
anOWL-based environment using the ontology editing tool
Prote´ge´ (12). The ontology is versioned and tracked using
a GitHub repository (https://github.com/geneontology/go-
ontology). One major advantage of the new ontology man-
agement process is that the work can be parallelized among
multiple editors, thus increasing efficiency. In addition, real-
time quality checks prevent errors that would otherwise re-
quire revisiting the same editing taskmore than once to cor-
rect them.
GO continues to integrate and align with external
ontology resources in two main ways: import of sub-
ontologies used to define GO terms, and inclusion of
external cross-references. GO utilizes the structure of
external ontologies to aid in reasoning and in the au-
tomatic inference of relations between GO terms (13).
GO imports subsets of these external ontologies that
include information about anatomical structures, cell
types, chemicals and taxonomic groupings: Uberon (14),
Protein Ontology (15), Plant Ontology (16), ChEBI
(17), Relations Ontology (18), NCBI Taxonomy (19),
Sequence Ontology (20), Ontology of Biological At-
tributes (http://www.obofoundry.org/ontology/oba.html),
Fungal Anatomy Ontology (http://www.obofoundry.
org/ontology/fao.html), Phenotypic Quality On-
tology (http://obofoundry.org/ontology/pato.html),
and Common Anatomy Reference Ontology (http:
//www.obofoundry.org/ontology/caro.html). GOalsomain-
tains cross-references between terms and multiple widely-
used external resources, including Reactome (21), The
Annotated Reactions Database (Rhea) (22), Enzyme Com-
mission (EC; http://www.sbcs.qmul.ac.uk/iubmb/enzyme/),
IntAct, Complex Portal (23) and MetaCyc (24).
Refactoring the molecular function branch of GO. Previ-
ously, there was a trend in GOmolecular function ontology
development to focus on adding terms that describe molec-
ular binding activities of specific gene products. The advan-
tage of such terms is that annotations can often bemade un-
equivocally based on results from a single experiment.How-
ever, this approach has led to a complex ontology structure
and a proliferation of annotations that individually repre-
sent only a partial functional description of a gene product.
Annotations to binding terms can obscure annotations to
more informative function terms, making annotationsmore
difficult to interpret. For example, one can annotate CDK1
(UniProtKB: P06493) separately with ‘GO:0030332 cyclin
binding’, ‘GO:0005524 ATP binding’, ‘GO:0005515 pro-
tein binding’, and ‘GO:0004674 protein serine/threonine
kinase activity’. However, these are all aspects of a more
precise molecular function that is more informative than
the sum of these parts: ‘GO:0004693 cyclin-dependent pro-
tein serine/threonine kinase activity’. In the GO molecu-
lar function refactoring, we recognized that, while specific
binding events are an essential mechanism by which gene
products function, an individual binding activity is almost
never sufficient in itself to describe molecular function in
a larger biological context (25). One of the primary goals
of our refactoring was to ensure that the ontology con-
tains the terms necessary to describe these higher-level func-
tions, and that they have a path to the root of the ontol-
ogy that is not simply under the generic ‘GO:0005488 bind-
ing’ term. Accordingly, we reinstated some previously ob-
soleted terms and added new terms, as well as additional
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relations. We also addressed the structure of the ontology
so that the upper-level terms would be more biologically
meaningful and have more uniform specificity. We removed
8 terms from the top level and added four new terms (Figure
2). Most of the terms that were formerly direct children of
‘GO:0003674 molecular function’ were moved under more
biologically meaningful terms: for example, ‘GO:0042056
chemoattractant activity’ and ‘GO:0045499 chemorepellent
activity’ were moved under ‘GO:0048018 receptor ligand
activity’, while ‘GO:0036370 D-alanyl carrier activity’ and
‘GO:0016530metallochaperone activity’ were moved under
the new term ‘GO:0140104 molecular carrier activity’ (rep-
resenting an activity of ‘directly binding to a specific ion or
molecule and delivering it either to an acceptor molecule
or to a specific location’). We have also created a new term
‘GO:0104005 hijacked molecular function’ as a parent of
terms such as ‘GO:0001618 virus receptor activity’, which
is, from the standpoint of the protein being annotated, not a
normal function, but nevertheless relevant for some of our
users.
Finally, we havemade significant changes to the structure
representing the molecular functions of transcription fac-
tors (Figure 3). This refactoring was carried out in collab-
oration with experts in transcription factors and gene reg-
ulation from the Gene Regulation Consortium (GRECO;
http://thegreco.org). In keeping with our design principle
of having terms that describe higher-level functions, we
have created a new parent term to group all functions
that directly regulate transcription, ‘GO:0140110 tran-
scription regulator activity’. The formerly top-level term
‘GO:0000988 transcription factor activity, protein binding’
has been obsoleted because this activity was partly cov-
ered by other terms in the ontology and its usage was in-
consistent. Accordingly, its children have either been obso-
leted or subsumed under different terms (merged ormoved).
The new top level term ‘GO:0140110 transcription reg-
ulator activity’ has three main children - ‘GO:0003700
DNA-binding transcription factor activity’ (formerly la-
beled ‘transcription factor activity, sequence-specific DNA
binding), ‘GO:0140223 general transcription initiation fac-
tor activity’ and ‘GO:0003712 transcription coregulator ac-
tivity’.
The transcription factor areas of GOhad previously been
refactored between 2010 and 2012 (26,27) with the aim of
more finely capturing all combinations of different types
of protein and DNA binding activities (e.g. binding to dif-
ferent types of regulatory regions such as promoters and
enhancers) and transcription regulation processes (positive
and negative regulation). However, this structure, while very
precise, has proved very difficult to use by biocurators, re-
sulting in inconsistent annotations. Additionally, end-users
have had difficulty with common queries, such as compre-
hensively identifying the set of all transcription factors in
a given species. We expect that even more improvements to
the ontology structure, as well as more consistent annota-
tions to transcription regulator terms, will be available in
2019.
Defining the boundaries of biological processes: MAP ki-
nase signaling and extracellular matrix as examples. We
have used our integrated annotation review and ontology
development methodology to refine two areas of the ontol-
ogy, theMAP kinase signaling pathway and the representa-
tion of the extracellular matrix. Refinements to the MAPK
cascade included defining the molecular functions that are
parts of the process: ‘GO:0004707 MAP kinase activity’,
‘GO:0004708 MAP kinase kinase activity, ‘GO:0004709
MAP kinase kinase kinase activity’ and ‘GO:0008349MAP
kinase kinase kinase kinase activity’. All other upstream
and downstream molecular functions/biological processes
will be modeled in GO-CAM with causal relationships be-
tween them and the MAPK cascade. We also enumerated
the types of cascades based on current literature and on
discussions among expert model-organism curators, trying
to keep the distinctions useful across multiple taxa. There
are four direct subtypes of ‘GO:0000165 MAPK cascade’:
‘GO:0070371 ERK1 and ERK2 cascade’, ‘GO:0070375
ERK5 cascade’, ‘GO:0071507 pheromone responseMAPK
cascade’ and ‘GO:0051403 stress-activated MAPK cas-
cade’. Some other MAPK processes such as ‘GO:1903616
MAPK cascade involved in axon regeneration’ will eventu-
ally be obsoleted, as these combine two or more other GO
terms and can be composed in GO-CAM. For the refine-
ment of the extracellular matrix area of the ontology, we
worked with external experts to add terms that were useful
grouping terms such as ‘GO:0062023 collagen-containing
extracellular matrix’. We also obsoleted or merged terms
thatwere poorly annotated and thought to represent an out-
dated view.
GO subsets (slims). A GO subset (or slim) is a set of GO
terms selected to provide an overview of the functions, lo-
cations or roles of a set of genes. The subset can be de-
veloped for high coverage of specific species, or to repre-
sent only certain areas of the ontology, and in most cases,
contain only high-level GO terms to provide a broad bi-
ological overview. Another use of subsets is to blacklist
certain terms for annotation: GO has two such subsets,
one to flag terms that should not be used for manual an-
notation, and one for terms that should not be used at
all. GO maintains two additional subsets, the Generic GO
slim and the Alliance of Genome Resources (https://www.
alliancegenome.org/) slim. GO also hosts subsets useful to
groups using GO; we currently have 11 such subsets (Ta-
ble 2; http://www.geneontology.org/page/go-subset-guide).
Each subset provides a global overview of gene functions.
Each subset now has a designated contact person to resolve
any issue resulting from ontology changes (see Ontology re-
vision and integration).
Other developments
The GO ribbon: a configurable tool for visualizing GO anno-
tations. Many genes have large numbers of annotations,
making it difficult to get a quick overview of a gene func-
tion, or the functions of gene sets. We have developed
the GO ribbon specifically to help users visualize and ex-
plore the functions of a gene. The GO ribbon visualization
metaphor borrows from a viewer originally developed by
theMouseGenomeDatabase team (28), but in contrast, the
GO ribbon was developed as a lightweight, reusable widget
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Figure 2. Themolecular function branch, before and after refactoring. The termmarked with an ‘x’ in the left-hand panel has been obsoleted. Terms moved
(assigned to a new parent) are indicated by arrows. New terms (right panel) are marked with ‘NEW’. 1The class label ‘electron carrier activity’ was changed
to ‘electron transfer activity’.
Figure 3. Current structure of the ‘GO:0140110 transcription regulator ac-
tivity’ branch of the ontology.
Table 2. Subsets maintained in GO
GO subsets
Generic GO subset
GO slim AGR
GO do not annotate list
GO do not manually annotate list
Subsets from external groups
Subset Group
Aspergillus subset Aspergillus Genome Data
Candida albicans Candida Genome Database
Chembl Drug Target subset ChEMBL
FlyBase Ribbon slim FlyBase
Metagenomics subset EBI Metagenomics group
Mouse GO slim MGI
Plant subset The Arabidopsis Information Resource
Protein Information Resource subset PIR
Schizosaccharomyces pombe subset PomBase
Synapse GO slim SynGO
Yeast subset Saccharomyces Genome Database
that can be embedded in any website, and retrieves data di-
rectly from the GO resource via API.
To generate aGO ribbon, all the functions (GO terms) as-
sociated with a gene of interest are mapped onto a specified
GO subset using the ontology structure. The end result is a
simple graphical representation of a gene’s functions (Fig-
ure 4). The ribbon is interactive, allowing users to drill down
to more specific functions by selecting a high-level category
such as ‘GO:0030154 cell differentiation’, ‘GO:0050877 ner-
vous system process’, or ‘GO:0003700 DNA-binding tran-
scription factor activity’, and to filter the functions based
on the evidence codes provided in the GO annotations.
This overview of gene functions is particularly useful when
comparing the functions of different genes in the same
species, or the functions of orthologous genes across differ-
ent species.
The GO ribbon is a React component available on
GitHub (https://github.com/geneontology/ribbon) and
as a NPM package https://www.npmjs.com/package/
@geneontology/ribbon). The GO ribbon widget is cur-
rently used by the Alliance of Genome Resources.
GO annotations from high-throughput experiments. Data
from high-throughput experiments are generally collected
in a hypothesis-free manner, and consequently do not gen-
erally provide as strong evidence of gene function as small-
scale molecular biology experiments that currently sup-
port most of the experimental GO annotations. In addi-
tion, high-throughput experiments can be subject to rela-
tively high false positive rates. Users may therefore want to
filter out these experimental annotations in some applica-
tions of the GO. To make this possible, starting in 2018, in
collaboration with the Evidence and Conclusions Ontology
(29) (2), the GO has added several new evidence codes to
describe high-throughput experiments: ‘ECO:0006056 high
throughput evidence used in manual assertion’ (HTP), and
the subclasses: ‘ECO:0007005 high throughput direct assay
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Figure 4. GO ribbon representation. Darker boxes indicate terms with the most annotations; white boxes represent terms that are not annotated for this
protein (Mus musculus Sox7, MGI:98369). Screenshot obtained from https://www.alliancegenome.org/gene/MGI:98369.
evidence used in manual assertion’ (HDA), ‘ECO:0007001
high throughput mutant phenotype evidence used in man-
ual assertion’ (HMP), ‘ECO:0007003 high throughput ge-
netic interaction evidence used in manual assertion’ (HGI)
and ‘ECO:0007007 high throughput expression pattern ev-
idence used in manual assertion’ (HEP). To accompany the
new evidence codes, we have provided annotation guidelines
to help identify and curate high-throughput datasets that
meet the GO Consortium annotation criteria. Consortium
members have reviewed papers with more than 40 annota-
tions using a single evidence code, and updated the evidence
codes, or removed the annotations if appropriate. There
are currently over 31 000 annotations that have HTP evi-
dence codes from 140 research articles, representing<5% of
experimental GO annotations. The identification of anno-
tations derived from high-throughput experiments allows
users to choose to exclude these from their analyses, if they
are concerned that these annotations may lead to an in-
creased bias in data analysis. This is likely to be particularly
important, as is often the case, whenGO is used to interpret
types of data similar to those on which the annotations are
based.
CONCLUSIONS
The GO resource has been under continuous development
for 20 years, with no signs of slowing down. Both the ontol-
ogy and annotations continue to be updated steadily, in re-
sponse to new experimental findings concerning gene func-
tion, and accumulating knowledge of how genes function
together in larger systems. The GO Consortium is increas-
ing efforts to review annotations, especially those that are
older and may have been superseded by newer findings. GO
has always been an open, community project, and we hope
that users of GO will contact us with suggestions for how
we can improve the resource. GO releases are now monthly,
with persistent DOI’s, and we recommend that all published
GO-based analyses cite this DOI, to enable reproducibility.
GO-CAM, our new framework for defining and represent-
ing gene functions withmore accuracy, consistency and pre-
cision, is being used to create a growing set of curated bio-
logical models, and we encourage the analysis tool devel-
oper community to explore the new format and potential
new applications of these models.
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